AbCellera Biologics (ABCL)
Discovers antibodies for partners and advances its own clinical candidates.
$12.22
vs last close−0.43 (−3.43%)
Something off on this page? Send us feedback.
Next report
Nov 5, 26
in 43 days
EPS estimate
−$0.18
Revenue estimate
$5.3M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported−$0.11−$0.15−$0.12−$0.19−$0.03−$0.14−$0.18Pending
Estimate−$0.15−$0.17−$0.17−$0.17−$0.18−$0.22−$0.16−$0.18
Surprise+26.7%+11.8%+29.4%−11.8%+83.3%+36.4%−9.8%—
RevenueReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$5.1M$4.2M$17.1M$9.0M$44.9M$8.3M$4.1MPending
Estimate$7.6M$7.3M$6.4M$6.3M$6.7M$5.4M$7.8M$5.3M
Surprise−33.4%−42.1%+168.6%+41.9%+572.9%+53.6%−48.4%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | $0.00 | — | — |
| Sep 2028 | $0.00 | — | — |
| Jun 2028 | $0.00 | — | — |
| Mar 2028 | $0.00 | — | — |
| Dec 2027 | −$0.21 | — | — |
| Sep 2027 | −$0.19 | — | — |
| Jun 2027 | −$0.20 | — | — |
| Mar 2027 | −$0.19 | — | — |
| Dec 2026 | −$0.17 | — | — |
| Nov 2026 | −$0.18 | — | — |
| Aug 2026 | −$0.16 | −$0.18 | −9.8% |
| May 2026 | −$0.22 | −$0.14 | +36.4% |
| Feb 2026 | −$0.18 | −$0.03 | +83.3% |
| Nov 2025 | −$0.17 | −$0.19 | −11.8% |
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Sep 2020 | |||
| Dec 2020 | |||
| Mar 2020 | |||
| Dec 2019 | |||
| Sep 2019 | |||
| Jun 2019 | |||
| Mar 2019 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | $0.00 | — | — | $5.0M | — | — | — |
| Sep 2028 | $0.00 | — | — | $5.0M | — | — | — |
| Jun 2028 | $0.00 | — | — | $5.0M | — | — | — |
| Mar 2028 | $0.00 | — | — | $5.0M | — | — | — |
| Dec 2027 | −$0.21 | — | — | $7.5M | — | — | — |
| Sep 2027 | −$0.19 | — | — | $9.8M | — | — | — |
| Jun 2027 | −$0.20 | — | — | $7.9M | — | — | — |
| Mar 2027 | −$0.19 | — | — | $7.8M | — | — | — |
| Dec 2026 | −$0.17 | — | — | $6.3M | — | — | — |
| Nov 5, 2026 | −$0.18 | — | — | $5.3M | — | — | — |
| Aug 5, 2026 | −$0.16 | −$0.18 | −9.8% | $7.8M | $4.1M | −48.4% | +10.3% |
| May 11, 2026 | −$0.22 | −$0.14 | +36.4% | $5.4M | $8.3M | +53.6% | −5.7% |
| Feb 24, 2026 | −$0.18 | −$0.03 | +83.3% | $6.7M | $44.9M | +572.9% | −0.9% |
| Nov 6, 2025 | −$0.17 | −$0.19 | −11.8% | $6.3M | $9.0M | +41.9% | −13.7% |
| Aug 7, 2025 | |||||||
| May 8, 2025 | |||||||
| Feb 27, 2025 | |||||||
| Nov 4, 2024 | |||||||
| Aug 6, 2024 | |||||||
| May 7, 2024 | |||||||
| Feb 20, 2024 | |||||||
| Nov 2, 2023 | |||||||
| Aug 3, 2023 | |||||||
| May 4, 2023 | |||||||
| Feb 21, 2023 | |||||||
| Nov 8, 2022 | |||||||
| Aug 9, 2022 | |||||||
| May 10, 2022 | |||||||
| Feb 24, 2022 | |||||||
| Nov 9, 2021 | |||||||
| Aug 12, 2021 | |||||||
| May 13, 2021 | |||||||
| Mar 29, 2021 | |||||||
| Sep 30, 2020 | |||||||
| Dec 14, 2020 | |||||||
| Mar 31, 2020 | |||||||
| Dec 31, 2019 | |||||||
| Sep 30, 2019 | |||||||
| Jun 30, 2019 | |||||||
| Mar 31, 2019 |